Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Invested Capital (2016 - 2025)

Fortress Biotech has reported Invested Capital over the past 13 years, most recently at $49.9 million for Q4 2025.

  • Quarterly results put Invested Capital at $49.9 million for Q4 2025, up 3133.64% from a year ago — trailing twelve months through Dec 2025 was $49.9 million (up 3133.64% YoY), and the annual figure for FY2025 was $49.9 million, up 3133.64%.
  • Invested Capital for Q4 2025 was $49.9 million at Fortress Biotech, down from $65.2 million in the prior quarter.
  • Over the last five years, Invested Capital for FBIO hit a ceiling of $248.3 million in Q2 2021 and a floor of -$15.9 million in Q2 2023.
  • Median Invested Capital over the past 5 years was $43.6 million (2025), compared with a mean of $78.4 million.
  • Biggest five-year swings in Invested Capital: crashed 203.59% in 2024 and later surged 3133.64% in 2025.
  • Fortress Biotech's Invested Capital stood at $225.9 million in 2021, then plummeted by 77.85% to $50.0 million in 2022, then crashed by 96.83% to $1.6 million in 2023, then crashed by 203.59% to -$1.6 million in 2024, then surged by 3133.64% to $49.9 million in 2025.
  • The last three reported values for Invested Capital were $49.9 million (Q4 2025), $65.2 million (Q3 2025), and $37.4 million (Q2 2025) per Business Quant data.